Covered recipient · General Payments record
BASSEM M CHEHAB
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2025 · Entire year
$88,917.99
152 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2025 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $59,262.50 | 16 |
| Travel and Lodging | $11,642.62 | 41 |
| Compensation for serving as faculty or as a speaker for a medical education program | $10,312.50 | 3 |
| Food and Beverage | $7,700.37 | 92 |
By paying entity
PY2025 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $45,988.87 | 55 |
| Edwards Lifesciences Corporation | $18,251.21 | 28 |
| ABIOMED | $8,527.81 | 13 |
| Biosense Webster, Inc. | $7,781.26 | 12 |
| CARDIVA MEDICAL, INC. | $2,614.78 | 7 |
| Medtronic, Inc. | $2,405.94 | 20 |
| Recor Medical Inc | $2,197.81 | 3 |
| Teleflex LLC | $811.74 | 7 |
| Potrero Medical, Inc. | $138.07 | 1 |
| BIOTRONIK INC. | $134.97 | 3 |
| Shockwave Medical, Inc | $28.00 | 1 |
| Philips North America LLC | $20.72 | 1 |
| Kestra Medical Technology Services, Inc. | $16.81 | 1 |
Page 4 of 4; records 151–152 of 152 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
BASSEM M CHEHAB
NPI 1710006820 · CMS profile ID 725450
Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease
WICHITA, KS
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 4 of 4; records 151–152 of 152 matching records. This page contains 2 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1710006820?year=2025&recipient=provider&page=4#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- BASSEM M CHEHAB, NPI 1710006820, CMS profile ID 725450. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–152 of 152 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1710006820?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- APA 7
- IndustryPayments. (2026). BASSEM M CHEHAB, NPI 1710006820, CMS profile ID 725450. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–152 of 152 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1710006820?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
- Bluebook
- BASSEM M CHEHAB, NPI 1710006820, CMS profile ID 725450, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–152 of 152 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1710006820?year=2025&recipient=provider&page=4#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30
152 matching records · $88,917.99 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 151–152 of 152.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| ABIOMED | $713.80 | 01/23/2025 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1174624921 | CMS |
| ABIOMED | $134.34 | 01/13/2025 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1174623918 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $582,334.39 | 119 |
| PY2024 | Principal investigator | $1,442,480.76 | 191 |
| PY2023 | Principal investigator | $549,514.11 | 116 |
| PY2022 | Principal investigator | $828,119.74 | 105 |
| PY2021 | Principal investigator | $647,203.76 | 125 |
| PY2020 | Principal investigator | $591,770.99 | 131 |
| PY2019 | Recipient | $1,000.00 | 1 |
| PY2019 | Principal investigator | $811,938.87 | 58 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
119 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Edwards Lifesciences Corporation | $6,195.70 | 12/23/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE 2021-05 | No dispute reported | 06/30/2026 | 1222705728 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $5,704.25 | 12/23/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | JOURNEY (Trial JCM-002) | No dispute reported | 06/30/2026 | 1222705730 |
| Principal investigator 1 | Medtronic, Inc. | $11,268.00 | 12/22/2025 | Non-covered Recipient Entity Ascension Via Christi Research | Prevail Global | No dispute reported | 06/30/2026 | 1192331697 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359412 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359414 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359416 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359418 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359420 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 12/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359422 |
| Principal investigator 1 | BIOTRONIK INC. | $73.13 | 12/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359404 |
| Principal investigator 1 | BIOTRONIK INC. | $211.26 | 12/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359406 |
| Principal investigator 1 | BIOTRONIK INC. | $377.01 | 12/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359408 |
| Principal investigator 1 | BIOTRONIK INC. | $422.51 | 12/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359410 |
| Principal investigator 1 | Abbott Laboratories | $19.77 | 12/17/2025 | Non-covered Recipient Entity MPX Group | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248160928 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,000.00 | 12/17/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE AVIV 2021-05 | No dispute reported | 06/30/2026 | 1222705724 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,000.00 | 12/17/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE 2021-05 | No dispute reported | 06/30/2026 | 1222705726 |
| Principal investigator 1 | Medtronic, Inc. | $7,356.00 | 12/17/2025 | Non-covered Recipient Entity Ascension Via Christi Research | SMART Trial | No dispute reported | 06/30/2026 | 1192321654 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $16,565.96 | 12/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial 2021-01 | No dispute reported | 06/30/2026 | 1222705722 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $2,860.00 | 12/12/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE AVIV 2021-05 | No dispute reported | 06/30/2026 | 1222705720 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $4,063.30 | 12/11/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705732 |
| Principal investigator 1 | Abbott Laboratories | $60.00 | 12/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248160436 |
| Principal investigator 1 | Abbott Laboratories | $1,580.00 | 11/24/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04011722--Portico Next Generation Approval Study | No dispute reported | 06/30/2026 | 1248159916 |
| Principal investigator 1 | BIOTRONIK INC. | $500.00 | 11/13/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359436 |
| Principal investigator 1 | Medtronic, Inc. | $16,186.00 | 11/13/2025 | Non-covered Recipient Entity Ascension Via Christi Research | Global Symplicity Registry Define | No dispute reported | 06/30/2026 | 1192331983 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $4,887.30 | 11/07/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | TRISCEND II Pivotal (2020-05) | No dispute reported | 06/30/2026 | 1222705718 |
| Principal investigator 1 | Biosense Webster, Inc. | $2,681.20 | 11/06/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination | No dispute reported | 06/30/2026 | 1175090421 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $5,600.00 | 11/06/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507860 |
| Principal investigator 1 | Abbott Laboratories | $989.91 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | No dispute reported | 06/30/2026 | 1248142244 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359424 |
| Principal investigator 1 | BIOTRONIK INC. | $1,387.26 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-48 | No dispute reported | 06/30/2026 | 1244359426 |
| Principal investigator 1 | BIOTRONIK INC. | $73.13 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359428 |
| Principal investigator 1 | BIOTRONIK INC. | $211.26 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359430 |
| Principal investigator 1 | BIOTRONIK INC. | $73.13 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359432 |
| Principal investigator 1 | BIOTRONIK INC. | $211.26 | 11/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244359434 |
| Principal investigator 1 | Abbott Laboratories | $8,753.50 | 11/03/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248159040 |
| Principal investigator 1 | Abbott Laboratories | $996.00 | 11/03/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04226547--Amplatzer Amulet LAAO vs. NOAC | No dispute reported | 06/30/2026 | 1248159074 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $2,860.00 | 10/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE AVIV 2021-05 | No dispute reported | 06/30/2026 | 1222705714 |
| Principal investigator 1 | Abbott Laboratories | $4,285.50 | 10/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05997446--Amulet ADVANCE LAA | No dispute reported | 06/30/2026 | 1248158780 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $770.00 | 10/24/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507866 |
| Principal investigator 1 | Abbott Laboratories | $3,700.00 | 10/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04177394--MitraClip EXPAND G4 Study | No dispute reported | 06/30/2026 | 1248158244 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $2,750.00 | 10/20/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705716 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,200.00 | 10/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | JOURNEY (Trial JCM-002) | No dispute reported | 06/30/2026 | 1222705704 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,750.00 | 10/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ExCEED Trial #2017-18 | No dispute reported | 06/30/2026 | 1222705706 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,750.00 | 10/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALLIANCE AVIV 2021-05 | No dispute reported | 06/30/2026 | 1222705708 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $780.60 | 10/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ExCEED Trial #2017-18 | No dispute reported | 06/30/2026 | 1222705710 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $761.30 | 10/16/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | Partner3 2015-08 | No dispute reported | 06/30/2026 | 1222705712 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $520.60 | 10/10/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ExCEED Trial #2017-18 | No dispute reported | 06/30/2026 | 1222705702 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,750.00 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial – Continued Access 2021-01-CAP | No dispute reported | 06/30/2026 | 1222705694 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $2,224.90 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | Early-TAVR Trial #2016-07 | No dispute reported | 06/30/2026 | 1222705696 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $520.60 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ExCEED Trial #2017-18 | No dispute reported | 06/30/2026 | 1222705698 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,333.80 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | Partner3 2015-08 | No dispute reported | 06/30/2026 | 1222705700 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,750.00 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507854 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,000.00 | 09/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507858 |
| Principal investigator 1 | Biosense Webster, Inc. | $38,993.85 | 09/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination | No dispute reported | 06/30/2026 | 1175090428 |
| Principal investigator 1 | Biosense Webster, Inc. | $2,500.00 | 09/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination | No dispute reported | 06/30/2026 | 1175090446 |
| Principal investigator 1 | Medtronic, Inc. | $1,750.00 | 09/26/2025 | Non-covered Recipient Entity Ascension Via Christi Research | SMART Trial | No dispute reported | 06/30/2026 | 1192321652 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,000.00 | 09/25/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ExCEED Trial #2017-18 | No dispute reported | 06/30/2026 | 1222705692 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $143.00 | 09/19/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705690 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,000.00 | 09/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial – Continued Access 2021-01-CAP | No dispute reported | 06/30/2026 | 1222705688 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $27,106.31 | 09/15/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | JOURNEY (Trial JCM-002) | No dispute reported | 06/30/2026 | 1222705686 |
| Principal investigator 1 | Procyrion, Inc. | $7,750.00 | 09/12/2025 | Covered Recipient Teaching Hospital VIA CHRISTI HOSPITAL WICHITA | DIURETICS ALONE VS. AORTIX ENDOVASCULAR DEVICE FOR ACUTE HEART FAILURE (DRAIN-HF) | No dispute reported | 06/30/2026 | 1251321104 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $1,750.00 | 09/09/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial 2021-01 | No dispute reported | 06/30/2026 | 1222705682 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $143.00 | 09/04/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705684 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,400.00 | 08/28/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507852 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $14,550.00 | 08/27/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507864 |
| Principal investigator 1 | Abbott Laboratories | $2,565.00 | 08/25/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04011722--Portico Next Generation Approval Study | No dispute reported | 06/30/2026 | 1248155888 |
| Principal investigator 1 | Abbott Laboratories | $2,847.00 | 08/18/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05423379--XIENCE Skypoint Large Vessel Post Approval Study | No dispute reported | 06/30/2026 | 1248155618 |
| Principal investigator 1 | Abbott Laboratories | $131.25 | 08/11/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03904147--TRILUMINATE Pivotal Trial | No dispute reported | 06/30/2026 | 1248141696 |
| Principal investigator 1 | Abbott Laboratories | $2,742.00 | 08/06/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05997446--Amulet ADVANCE LAA | No dispute reported | 06/30/2026 | 1248155238 |
| Principal investigator 1 | CathWorks, Inc. | $2,000.00 | 08/05/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | ALL-RISE | No dispute reported | 06/30/2026 | 1249383988 |
| Principal investigator 1 | Abbott Laboratories | $21,752.00 | 08/04/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248154930 |
| Principal investigator 1 | Abbott Laboratories | $3,755.00 | 08/04/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04226547--Amplatzer Amulet LAAO vs. NOAC | No dispute reported | 06/30/2026 | 1248155064 |
| Principal investigator 1 | Medtronic, Inc. | $1,000.00 | 08/01/2025 | Non-covered Recipient Entity Ascension Via Christi Research | SMART Trial | No dispute reported | 06/30/2026 | 1192321650 |
| Principal investigator 1 | Medtronic, Inc. | $20,157.00 | 08/01/2025 | Non-covered Recipient Entity Ascension Via Christi Research | Prevail Global | No dispute reported | 06/30/2026 | 1192331695 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $4,182.70 | 07/31/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | TRISCEND II Pivotal (2020-05) | No dispute reported | 06/30/2026 | 1222705678 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $17,470.44 | 07/31/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705680 |
| Principal investigator 1 | Abbott Laboratories | $3,843.90 | 07/30/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | No dispute reported | 06/30/2026 | 1248141546 |
| Principal investigator 1 | Abbott Laboratories | $1,750.00 | 07/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04177394--MitraClip EXPAND G4 Study | No dispute reported | 06/30/2026 | 1248153468 |
| Principal investigator 1 | Abbott Laboratories | $1,750.00 | 07/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248153488 |
| Principal investigator 1 | Abbott Laboratories | $1,750.00 | 07/29/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04011722--Portico Next Generation Approval Study | No dispute reported | 06/30/2026 | 1248153490 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $2,750.00 | 07/25/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas | TRISCEND II Pivotal (2020-05) | No dispute reported | 06/30/2026 | 1222705310 |
| Principal investigator 1 | Abbott Laboratories | $18.93 | 07/17/2025 | Non-covered Recipient Entity MPX Group | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248153148 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $3,354.08 | 07/17/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial 2021-01 | No dispute reported | 06/30/2026 | 1222705674 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $13,708.58 | 07/17/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | The PROGRESS Trial 2021-01 | No dispute reported | 06/30/2026 | 1222705676 |
| Principal investigator 1 | Abbott Laboratories | $1,750.00 | 07/15/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | No dispute reported | 06/30/2026 | 1248141466 |
| Principal investigator 1 | Abbott Laboratories | $1,750.00 | 07/15/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03904147--TRILUMINATE Pivotal Trial | No dispute reported | 06/30/2026 | 1248141470 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $12,142.19 | 07/10/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas | The PROGRESS Trial 2021-01 | No dispute reported | 06/30/2026 | 1222705308 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $11,900.00 | 07/09/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507850 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,750.00 | 07/08/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507862 |
| Principal investigator 1 | Abbott Laboratories | $60.00 | 07/07/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248157386 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $18,000.00 | 07/07/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | JOURNEY (Trial JCM-002) | No dispute reported | 06/30/2026 | 1222705670 |
| Principal investigator 1 | Medtronic, Inc. | $2,080.00 | 07/03/2025 | Non-covered Recipient Entity Ascension Via Christi Research | SMART Trial | No dispute reported | 06/30/2026 | 1192321648 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $8,992.00 | 06/26/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705672 |
| Principal investigator 1 | Abbott Laboratories | $5,239.50 | 06/23/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05423379--XIENCE Skypoint Large Vessel Post Approval Study | No dispute reported | 06/30/2026 | 1248151956 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $550.00 | 06/18/2025 | Covered Recipient Teaching Hospital Ascension St. Vincent Hospital | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507152 |
| Principal investigator 1 | Abbott Laboratories | $1,275.00 | 06/09/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04177394--MitraClip EXPAND G4 Study | No dispute reported | 06/30/2026 | 1248151686 |
| Principal investigator 1 | Abbott Laboratories | $2,045.00 | 05/14/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04226547--Amplatzer Amulet LAAO vs. NOAC | No dispute reported | 06/30/2026 | 1248151052 |
| Principal investigator 1 | Abbott Laboratories | $19,837.50 | 05/12/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03904147--TRILUMINATE Pivotal Trial | No dispute reported | 06/30/2026 | 1248141216 |
| Principal investigator 1 | Abbott Laboratories | $40,126.75 | 05/12/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248150782 |
| Principal investigator 1 | Abbott Laboratories | $245.00 | 05/12/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT04011722--Portico Next Generation Approval Study | No dispute reported | 06/30/2026 | 1248150866 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $2,520.00 | 05/12/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507366 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $8,734.60 | 05/01/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | TRISCEND II Pivotal (2020-05) | No dispute reported | 06/30/2026 | 1222705668 |
| Principal investigator 1 | Abbott Laboratories | $7,717.15 | 04/28/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | No dispute reported | 06/30/2026 | 1248141080 |
| Principal investigator 1 | Abbott Laboratories | $555.50 | 04/23/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT05423379--XIENCE Skypoint Large Vessel Post Approval Study | No dispute reported | 06/30/2026 | 1248150134 |
| Principal investigator 1 | Abbott Laboratories | $6,507.00 | 04/21/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05997446--Amulet ADVANCE LAA | No dispute reported | 06/30/2026 | 1248150066 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $3,249.95 | 03/31/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas | ALLIANCE AVIV 2021-05 | No dispute reported | 06/30/2026 | 1222705304 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $9,960.55 | 03/31/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas | ALLIANCE 2021-05 | No dispute reported | 06/30/2026 | 1222705306 |
| Principal investigator 1 | Abbott Laboratories | $33,599.25 | 03/26/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | No dispute reported | 06/30/2026 | 1248147886 |
| Principal investigator 1 | Abbott Laboratories | $3,325.00 | 03/17/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT02000115--Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial | No dispute reported | 06/30/2026 | 1248147674 |
| Principal investigator 1 | Biosense Webster, Inc. | $6,526.30 | 03/17/2025 | Covered Recipient Teaching Hospital Via Christi Hospital Wichita | A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination | No dispute reported | 06/30/2026 | 1175090437 |
| Principal investigator 1 | Abbott Laboratories | $2,128.75 | 02/24/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT04198870--MitraClip REPAIR MR Study | No dispute reported | 06/30/2026 | 1248147014 |
| Principal investigator 1 | Procyrion, Inc. | $4,816.50 | 02/20/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS, LLC | DIURETICS ALONE VS. AORTIX ENDOVASCULAR DEVICE FOR ACUTE HEART FAILURE (DRAIN-HF) | No dispute reported | 06/30/2026 | 1251321114 |
| Principal investigator 1 | BIOTRONIK INC. | $1,750.00 | 02/19/2025 | Non-covered Recipient Entity CARDIOVASCULAR CONSULTANTS OF KANSAS, PA | BIOFLOW-VII | No dispute reported | 06/30/2026 | 1244358740 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $2,270.00 | 01/31/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507344 |
| Principal investigator 1 | Abbott Laboratories | $3,440.90 | 01/27/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation | No dispute reported | 06/30/2026 | 1248140248 |
| Principal investigator 1 | Abbott Laboratories | $3,245.00 | 01/27/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT04226547--Amplatzer Amulet LAAO vs. NOAC | No dispute reported | 06/30/2026 | 1248144922 |
| Principal investigator 1 | Abbott Laboratories | $520.00 | 01/27/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT04011722--Portico Next Generation Approval Study | No dispute reported | 06/30/2026 | 1248145382 |
| Principal investigator 1 | Edwards Lifesciences Corporation | $4,546.00 | 01/23/2025 | Non-covered Recipient Entity Cardiovascular Research Institute of Kansas | THE ENCIRCLE Trial (#2018-19) | No dispute reported | 06/30/2026 | 1222705302 |
| Principal investigator 1 | Abbott Laboratories | $2,840.00 | 01/22/2025 | Non-covered Recipient Entity CARDIOVASCULAR RESEARCH INSTITUTE OF KANSAS LLC | NCT04177394--MitraClip EXPAND G4 Study | No dispute reported | 06/30/2026 | 1248145360 |